⚠️ Research Use Only — Compounds discussed are research chemicals, not FDA-approved for human use. Not medical advice. Full disclaimers →
Also known as: Tα1, Zadaxin
Thymosin Alpha-1 is a immune peptide research compound (not FDA-approved for human use) studied for immune support. Thymosin Alpha-1 is an immune-modulating peptide approved in over 35 countries for treating hepatitis B and C, studied for enhancing T-cell activity and immune resilience against infection. Research dose: 1.50–1.50 mg 2x/wk. Half-life: 2 hours. Available from COA-verified vendors with code PEPTIDEX for up to 20% off.
Rankings independent · Research use only
Enhances T-cell function, boosts dendritic cell activity, and modulates cytokine production. Shifts immune response toward effective pathogen clearance.
COA-verified vendors · Use code PEPTIDEX for up to 20% off
* Prices for research peptide acquisition. Not therapeutic products.
| Vendor | Purity | List Price | With PEPTIDEX | Code | Shop |
|---|---|---|---|---|---|
| 98%+ | $78.0010 mg | $39.00Save 50% | PEPTIDEX | * Research vendor — verify your regional regulations before purchase. Shop | |
| 99%+ | $129.9710 mg | $110.47Save 15% | PEPTIDEX | * Research vendor — verify your regional regulations before purchase. Shop |
Use code PEPTIDEX for 50% off at Ascension Peptides.
* Research vendor — verify your regional regulations before purchase.
Shop at Ascension PeptidesUse code PEPTIDEX for 15% off at Bio Longevity Labs.
* Research vendor — verify your regional regulations before purchase.
Shop at Bio Longevity LabsEnhances T-cell function, boosts dendritic cell activity, and modulates cytokine production. Shifts immune response toward effective pathogen clearance.
Garaci et al.: Review of Tα1 use in immune-compromised patients showing enhanced T-cell function, improved dendritic cell activity, and cytokine modulation.
Moderate-StrongKing & Tuthill: Comprehensive review of 30+ clinical trials involving 11,000+ subjects confirming Tα1's consistent safety and efficacy across hepatitis B/C, cancer, and infections.
StrongMutchnick et al. (Hepatology): Randomized trial showing Tα1 combined with interferon significantly improves virologic response in chronic hepatitis B vs. interferon alone.
StrongEvidence review of Tα1 in septic shock, ARDS, and peritonitis showing improved survival and immune recovery in critically ill patients.
Moderate-StrongGaraci et al. (Ann. N.Y. Acad. Sci.): Review of Tα1 as cancer immunotherapy adjunct, showing enhanced chemotherapy tolerance and improved immune recovery in multiple tumor types.
ModerateA study published in Frontiers in immunology investigating the effects and mechanisms.
ModerateA study published in Expert opinion on biological therapy investigating the effects and mechanisms.
PreclinicalA study published in International immunopharmacology investigating the effects and mechanisms.
PreclinicalA study published in Cell reports. Medicine investigating the effects and mechanisms.
PreclinicalA study published in Future microbiology investigating the effects and mechanisms.
PreclinicalApproved in 35+ countries for hep B/C. One of the most extensively studied peptides. Not FDA-approved in US.
See our evidence grading methodology for how we evaluate and grade peptide safety data.
* Dosing data from published literature — not a human use recommendation.
Standard dose: 1.6mg 2x/week. Approved in 35+ countries. Higher doses for active infection.
Last updated: 2026-01 · Laws change frequently. Verify current status in your jurisdiction.
Week 1
NK cell and T-cell activation begins; improved energy if immune-suppressed
Weeks 2–4
Enhanced immune response to pathogens; reduced frequency of illness
Month 2–3
Sustained immune modulation; improved recovery from illness
Long-term
Long-term immune resilience; approved use in 35+ countries for hepatitis therapy
| Side Effect | Incidence | Severity |
|---|---|---|
Injection site reaction | ~5% of users | mild |
Mild flu-like symptoms (immune activation) Indicates immune activation; usually transient | ~5% of users | mild |
Finding verified, high-purity Thymosin Alpha-1 requires rigorous COA verification. We independently evaluate vendors based on third-party HPLC testing, purity thresholds (≥98%), and batch-specific documentation.
View COA-Verified Thymosin Alpha-1✓ Third-party tested·✓ US shipping·✓ COA on every batch
Disclosure: PeptiDex may earn a commission from purchases made through affiliate links. This does not affect our editorial independence or recommendations. We exclusively feature vendors that pass our strict quality verification protocols.
Strengthen adaptive immune function and provide direct defense against pathogenic threats
⚠️ Educational only · Not medical advice · For research use only. Information on this page is compiled from peer-reviewed literature and is intended strictly for educational and informational purposes. Peptides discussed may be unapproved research chemicals — consult a licensed healthcare professional before considering any peptide compound. Read our full disclaimer
Affiliate disclosure: PeptiDex may earn commissions from purchases made through vendor links on this page. This does not affect our editorial ranking or vendor recommendations — we exclusively feature vendors that pass independent COA verification. See our methodology · Editorial policy
12stacks • exact dosages • cycle lengths • printable reference
No spam. Unsubscribe anytime.
Independent researcher, not a medical professional
PeptiDex Research is the byline used by the independent researcher who builds and maintains PeptiDex. The site is a one-person research project — there is no editorial board, no medical reviewers, and no clinical staff. Content is produced by reading...
View profile